Sep 28

SS 22 - Some crHEME with Your Coffee? A Winning Blend of Radiation and Systemic Therapy in Hematologic Malignancies

204 - Tislelizumab plus P-GemOx-14 and Radiotherapy for Early-Stage High-Risk Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Phase 2 Trial

10:55am - 11:05am ET

Room 259

Presenter(s)

Shunan Qi, MD, MB - Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing